XVIVO PERFUSION AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 377 SEK | +1.07% |
|
+20.06% | +14.42% |
| 24/04 | Nordic Shares Declined Wednesday; Svenska Handelsbnkn Ser A Fell Furthest | DJ |
| 24/04 | Transcript : Xvivo Perfusion AB, Q1 2024 Earnings Call, Apr 24, 2024 |
Chart calendar Xvivo Perfusion AB
d59af97bb64.qgyREaO4zNMvqy88CjTii0WypbDkke86IAMzgg2zNac.8Hbae87ghLpfxVdxRUzauhX75NrSo4BWGHpG0mrcVtLeQ95dyfL1uHeaYg~b45493ae0832556f6140a093bbc4b541
Upcoming events on Xvivo Perfusion AB
Past events on Xvivo Perfusion AB
| 25/04/2024 05:30 pm | Annual General Meeting |
| 24/04/2024 05:30 pm | Q1 2024 Earnings Call |
| 24/04/2024 11:00 am | Q1 2024 Earnings Release |
| 25/01/2024 06:30 pm | Q4 2023 Earnings Call |
| 25/01/2024 12:00 pm | Q4 2023 Earnings Release |
| 24/10/2023 05:30 pm | Q3 2023 Earnings Call |
| 24/10/2023 11:00 am | Q3 2023 Earnings Release |
| 13/07/2023 05:30 pm | Q2 2023 Earnings Call |
| 13/07/2023 11:00 am | Q2 2023 Earnings Release |
| 25/04/2023 06:30 pm | Annual General Meeting |
| 24/04/2023 05:30 pm | Q1 2023 Earnings Call |
| 24/04/2023 11:00 am | Q1 2023 Earnings Release |
| 07/03/2023 10:30 am | Redeye Commercialization Seminar |
| 26/01/2023 06:30 pm | FY 2022 Earnings Call |
| 26/01/2023 12:00 pm | FY 2022 Earnings Release |
| 27/11/2022 | Redeye Life Science Day |
| 27/10/2022 05:30 pm | Q3 2022 Earnings Call |
| 27/10/2022 11:00 am | Q3 2022 Earnings Release |
| 21/09/2022 05:30 pm | Capital Markets Day |
| 13/07/2022 05:30 pm | Interim 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 221 223 -0.9% | 180 207 -13.16% | 258 261 -1.12% | 415 401 3.61% | 598 615 -2.8% | 795 |
|
EBITDA Million SEK | Released Forecast Spread | 28,8 33,6 -14.38% | -15,6 24,8 -162.95% | 13,8 31,1 -55.78% | 48,6 54,0 -10.08% | 80,5 88,5 -9.01% | 149 |
|
EBIT Million SEK | Released Forecast Spread | 3,90 9,66 -59.64% | -45,7 -4,71 -869.02% | -18,5 1,77 -1142.43% | 6,41 12,2 -47.5% | 4,19 29,9 -85.99% | 77,3 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 5,29 15,3 -65.45% | -57,3 -3,00 -1809.33% | 6,67 18,7 -64.33% | 22,3 30,0 -25.69% | 94,5 40,2 135.11% | 94,1 |
|
Net income Million SEK | Released Forecast Spread | 4,90 12,8 -61.76% | -43,7 -2,36 -1751.57% | 8,15 19,3 -57.75% | 18,4 25,5 -27.76% | 91,8 32,3 184.6% | 78,7 |
|
EPS SEK | Released Forecast Spread | 0,19 0,48 -60.36% | -1,61 -0,08 -1984.68% | 0,28 0,68 -59.06% | 0,62 0,86 -27.49% | 3,07 1,04 194.15% | 2,35 |
| Announcement Date | 30/01/20 | 28/01/21 | 27/01/22 | 26/01/23 | 25/01/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 92,7 84,9 9.18% | 94,3 93,2 1.15% | 96,8 95,9 1.02% | 132 117 12.57% | 141 132 6.18% | 155 145 6.25% | 147 157 -6.49% | 156 173 -9.96% | 186 169 10.07% | 190 | 198 | 218 | 265 | 242 |
|
EBITDA Million SEK | Released Forecast Spread | 14,7 5,76 155.05% | 14,4 13,1 9.59% | 5,90 14,8 -59.98% | 13,6 22,4 -39.4% | 24,9 25,1 -0.84% | 17,2 18,6 -7.34% | 18,9 20,2 -6.05% | 20,7 31,1 -33.38% | 36,9 27,0 36.61% | 33,5 | 35,8 | 43,8 | 64,0 | 78,0 |
|
EBIT Million SEK | Released Forecast Spread | 4,62 -2,19 311.23% | 4,14 4,14 -0.02% | -4,66 4,89 -195.31% | 2,30 12,3 -81.28% | 12,5 13,9 -10.41% | 3,80 14,4 -73.6% | 5,30 7,55 -29.78% | -16,1 17,9 -190.22% | 19,9 10,0 99.37% | 15,6 | 17,5 | 24,9 | 40,0 | 50,0 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 6,19 -0,19 3373.39% | 10,4 3,28 216.73% | 2,99 4,36 -31.36% | 2,75 13,3 -79.33% | 16,6 14,4 15.05% | 11,4 -1,04 1199.69% | 0,95 8,60 -88.91% | 65,6 14,7 346.14% | 30,0 9,50 215.87% | 16,2 | 17,5 | 25,2 | 40,0 | 50,0 |
|
Net income Million SEK | Released Forecast Spread | 4,77 -0,59 908.9% | 7,53 0,58 1203.08% | 5,40 2,06 162.15% | 0,73 11,0 -93.33% | 14,2 10,6 33.76% | 6,89 -4,54 251.66% | 2,28 5,30 -56.91% | 68,5 12,2 463.16% | 22,8 7,50 203.8% | 12,8 | 18,0 | 20,2 | 32,0 | 40,0 |
|
EPS SEK | Released Forecast Spread | 0,16 -0,02 896.42% | 0,26 0,02 1229.92% | 0,18 0,08 112.06% | 0,02 0,37 -94.62% | 0,48 0,36 34.5% | 0,23 0,17 32.39% | 0,08 0,34 -76.38% | 2,17 0,52 314.12% | 0,72 0,25 193.88% | 0,50 | 0,53 | 0,76 | 1,01 | 1,27 |
| Announcement Date | 25/04/22 | 13/07/22 | 27/10/22 | 26/01/23 | 24/04/23 | 13/07/23 | 24/10/23 | 25/01/24 | 24/04/24 | - | - | - | - | - |
| Today 01:35 am | SILK ROAD MEDICAL, INC: Q1 2024 Earnings Release |
| Today 01:35 am | MERIT MEDICAL SYSTEMS, INC.: Q1 2024 Earnings Release |
| 01/05/2024 | REPLIGEN CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 | BAUSCH + LOMB CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 | PROCEPT BIOROBOTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 03:30 pm | LIVANOVA PLC: Q1 2024 Earnings Release |
| 01/05/2024 04:00 pm | CENCORA, INC.: Q2 2024 Earnings Release |
| 02/05/2024 01:31 am | ATRICURE, INC.: Q1 2024 Earnings Release |
| 02/05/2024 01:40 am | ENVISTA HOLDINGS CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 | TANDEM DIABETES CARE, INC.: Q1 2024 Earnings Release |
Past sector events for Xvivo Perfusion AB
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- XVIVO Stock
- Calendar Xvivo Perfusion AB
